0001493152-24-009384.txt : 20240308
0001493152-24-009384.hdr.sgml : 20240308
20240308160528
ACCESSION NUMBER: 0001493152-24-009384
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240307
FILED AS OF DATE: 20240308
DATE AS OF CHANGE: 20240308
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Samuel George A. III
CENTRAL INDEX KEY: 0001878732
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-12830
FILM NUMBER: 24734305
MAIL ADDRESS:
STREET 1: C/O LINEAGE CELL THERAPEUTICS, INC.
STREET 2: 2173 SALK AVENUE, SUITE 200
CITY: CARLSBAD
STATE: CA
ZIP: 92008
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Lineage Cell Therapeutics, Inc.
CENTRAL INDEX KEY: 0000876343
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 943127919
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2173 SALK AVENUE
STREET 2: SUITE 200
CITY: CARLSBAD
STATE: CA
ZIP: 92008
BUSINESS PHONE: 5105213390
MAIL ADDRESS:
STREET 1: 2173 SALK AVENUE
STREET 2: SUITE 200
CITY: CARLSBAD
STATE: CA
ZIP: 92008
FORMER COMPANY:
FORMER CONFORMED NAME: BIOTIME INC
DATE OF NAME CHANGE: 19930328
4
1
ownership.xml
X0508
4
2024-03-07
0
0000876343
Lineage Cell Therapeutics, Inc.
LCTX
0001878732
Samuel George A. III
2173 SALK AVENUE, SUITE 200
CARLSBAD
CA
92008
0
1
0
0
General Counsel/Secretary
0
Employee Stock Option (Right to Buy)
1.13
2024-03-07
4
A
0
650000
0.00
A
2034-03-07
Common Shares
650000
650000
D
One quarter of the options shall vest on March 7, 2025, and the balance shall vest in 36 monthly installments thereafter upon the completion of each month of continuous employment.
/s/ George A. Samuel III
2024-03-08